The 2019 Road to Victory event will take one big team of 30 cyclists winding through small Vermont villages at the height of New England’s iconic fall foliage.
The team will pedal across covered bridges and past babbling brooks while challenging themselves over rolling hills. They will bid farewell to the Green Mountain State as their journey takes them over the international border and into Quebec – crossing the border in a peloton of bikes is quite the experience! This team will catch stunning views of Lake Memphremagog and soak in this glacier-carved landscape offering incredible vistas with exhilarating elevation gain!
R2V Team members took on a 3-day, bike ride from through the English countryside to the villages on France, and finally along the Champs de Elyse to the finish line: The Eiffel Tower.
The 6-Day ride took R2V team on a beautiful, challenging 300 mile journey through Glacier National Park and on to Canada’s Waterton Lakes National Park.
R2V team members were challenged to six days of epic riding through Utah’s Bryce Canyon and Zion National Park.
Seven cyclists, all with a direct connection to multiple myeloma, rode 3,400 miles from Manhattan Beach, California to Fairfield, Connecticut, to kick off the Road to Victories Program.
The cross-country riders were escorted on the first seven days of the ride by a group of 11 Road to Victories team members. This grueling 544 miles took riders from LA through the Mojave Desert and then up the mountains to Flagstaff, AZ.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More
